Walgreens expands availability of naloxone without a prescription
DEERFIELD, Ill. — Walgreens has expanded the availability of prescription-free naloxone to 33 states and the District of Columbia.
The medication can be dispensed in accordance with each state’s pharmacy regulations at nearly 5,800 Walgreens pharmacies. Naloxone can be used in the event of an overdose to reverse the effects of heroin or other opioid drugs, and is administered by injection or nasal spray.
“By making naloxone available without a prescription, we are making it easier for families and caregivers to help their loved ones by having it on hand in case it’s needed,” said Rick Gates, Walgreens group vice president of pharmacy. “As a pharmacy we are here to help people, and we are committed to making naloxone more accessible in the communities we serve.”
Walgreens will continue make the medication available in more states without a prescription. By early 2017 the company plans to begin offering naloxone without requiring a prescription in Arkansas, California, Connecticut, Iowa, Kentucky, Nevada and Tennessee.
States where Walgreens offers naloxone without requiring a prescription:
Alabama, Colorado, District of Columbia, Florida, Idaho, Illinois, Indiana, Louisiana, Maine, Maryland, Massachusetts, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Hampshire, New Jersey, New Mexico, New York (including Duane Reade pharmacies), North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Texas, Utah, Vermont, Virginia, Washington, West Virginia and Wisconsin.
No comments found
Janssen seeks approval of Simponi Aria for psoriatic arthritis and ankylosing spondylitis
HORSHAM, Pa. — Janssen Biotech submitted two Supplemental Biologics License Applications to the U.S. Food and Drug Administration seeking approval of its Simponi Aria (golimumab) for the treatment of adults living with active psoriatic arthritis and the treatment of adults living with active ankylosing spondylitis. Psoriatic arthritis and ankylosing spondylitis are chronic, systemic inflammatory conditions that combined affect more than 2 million Americans.
"At Janssen, we are committed to addressing the unmet medical needs of patients living with psoriatic arthritis and ankylosing spondylitis through the discovery and development of innovative therapeutics," said Newman Yeilding, M.D, head of Immunology Development, Janssen Research and Development. "We understand the need for additional treatment options for patients and their healthcare providers and hope to make Simponi Aria available for those in need."
Simponi Aria is an infusible, fully human anti-TNF-alpha monoclonal antibody that targets both soluble and transmembrane bioactive forms of TNF-alpha, a protein that when overproduced in the body due to chronic inflammatory diseases can cause inflammation and damage to bones, cartilage and tissue. It is currently approved as a 30-minute intravenous infusion for the treatment of adult patients with moderately to severely active rheumatoid arthritis in combination with methotrexate.
According to Horsham-based Janseen Biotech, data from two separate Phase 3 studies evaluating the efficacy and safety of Simponi Aria 2 mg/kg given as an intravenous infusion every eight weeks after two starter doses at weeks zero and 4 in the treatment of adults living with active psoriatic arthritis (GO-VIBRANT) and active ankylosing spondylitis (GO-ALIVE) served as the basis for the submissions.
Simponi Aria is an infusible, fully human anti-TNF-alpha monoclonal antibody that targets both soluble and transmembrane bioactive forms of TNF-alpha, a protein that when overproduced in the body due to chronic inflammatory diseases can cause inflammation and damage to bones, cartilage and tissue.
No comments found
Pharmacists held in high regard
NEW YORK — Pharmacists rank second when it comes to honesty and ethical values, behind only nurses, according to an annual Gallup poll.
Of those surveyed, two-thirds rated pharmacists with a very high or high grade, while only 8% gave pharmacists a low or very low score.
“The rating that pharmacists earned in this annual Gallup survey is built on established pharmacist-patient relationships in neighborhoods throughout the nation. The takeaway for policymakers is that the pharmacist-patient relationship has tremendous potential to do even more to improve patient health and well-being, along with the overall quality and affordability of healthcare,” said NACDS President and CEO Steven C. Anderson, IOM, CAE.
Nurses received a very high or high grade from 84% percent of those surveyed, with only 3 percent giving them a negative rating. Nurses have ranked No. 1 on the list every year but once since 1999.
Medical doctors ranked third on the survey, followed by engineers and dentists.
“We commend community pharmacists across the country on their impressive showing in the latest Gallup survey of Americans’ views of honesty and ethical standards. People continue to hold pharmacists in very high regard. In this survey covering 22 professions, pharmacists are the second most trusted,” said B. Douglas Hoey, CEO of the National Community Pharmacists Association. “It is time for payers and policymakers to better utilize the accessibility, expertise and public trust in pharmacists. NCPA will carry that message into 2017 as health care reform efforts accelerate and the shift toward a value-based care system continues.”
On the flip side, members of Congress ranked last on the list, with only 8% giving them a high grade. Car salespeople ranked second from the bottom on the survey.
We/DMD work with thousands of retail, specialty, and hospital pharmacists each year. Our research aligns well with these findings - a very professional and trustworthy group of people.